HB 409 — An Act amending the act of October 24, 2018 (P.L.719, No.112), known as the Patient Test Result Information Act, further providing for definitions, for test results and for duties of Department of Health.
Congress · introduced 2025-01-29
Latest action: — Referred to HEALTH AND HUMAN SERVICES, April 21, 2025
Sponsors
- Bridget M. Kosierowski (D, PA-114) — sponsor · 2025-01-29
- Carol Hill-Evans (D, PA-95) — cosponsor · 2025-01-29
- Arvind Venkat (D, PA-30) — cosponsor · 2025-01-29
- Kyle Donahue (D, PA-113) — cosponsor · 2025-01-29
- Benjamin V. Sanchez (D, PA-153) — cosponsor · 2025-01-29
- Robert Freeman (D, PA-136) — cosponsor · 2025-01-29
- Ed Neilson (D, PA-174) — cosponsor · 2025-01-29
- Christopher M. Rabb (D, PA-200) — cosponsor · 2025-01-29
- Perry S. Warren (D, PA-31) — cosponsor · 2025-01-29
- Jose Giral (D, PA-180) — cosponsor · 2025-01-29
- Tarah Probst (D, PA-189) — cosponsor · 2025-01-29
- Mandy Steele (D, PA-33) — cosponsor · 2025-01-29
- Danielle Friel Otten (D, PA-155) — cosponsor · 2025-01-29
- Dan K. Williams (D, PA-74) — cosponsor · 2025-01-29
- La'Tasha D. Mayes (D, PA-24) — cosponsor · 2025-01-29
- Malcolm Kenyatta (D, PA-181) — cosponsor · 2025-01-29
- Nancy Guenst (D, PA-152) — cosponsor · 2025-01-29
- Robert E. Merski (D, PA-2) — cosponsor · 2025-01-29
- Heather Boyd (D, PA-163) — cosponsor · 2025-01-29
- Gina H. Curry (D, PA-164) — cosponsor · 2025-01-29
- G. Roni Green (D, PA-190) — cosponsor · 2025-01-29
- Joe Webster (D, PA-150) — cosponsor · 2025-01-29
- III John C. Inglis (D, PA-38) — cosponsor · 2025-01-29
- Bryan Cutler (R, PA-100) — cosponsor · 2025-01-29
- Lisa A. Borowski (D, PA-168) — cosponsor · 2025-01-29
- Keith S. Harris (D, PA-195) — cosponsor · 2025-01-29
- Tina M. Davis (D, PA-141) — cosponsor · 2025-01-29
- Carol Kazeem (D, PA-159) — cosponsor · 2025-01-29
Action timeline
- · house — Referred to HEALTH, Jan. 29, 2025
- · house — Reported as amended, Feb. 5, 2025
- · house — First consideration, Feb. 5, 2025
- · house — Laid on the table, Feb. 5, 2025
- · house — Removed from table, March 18, 2025
- · house — Second consideration, March 19, 2025
- · house — Re-committed to APPROPRIATIONS, March 19, 2025
- · house — Re-reported as committed, April 7, 2025
- · house — Third consideration and final passage, April 7, 2025 (202-1)
- · senate — In the Senate
- · senate — Referred to HEALTH AND HUMAN SERVICES, April 21, 2025
- · house — (Remarks see House Journal Page 325-327), April 7, 2025
Text versions
No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.
Bill text
Printer's No. 0381 · 10,833 characters · source document
Read the full text
PRINTER'S NO. 381
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 409
Session of
2025
INTRODUCED BY KOSIEROWSKI, HILL-EVANS, VENKAT, DONAHUE, SANCHEZ,
FREEMAN, NEILSON, RABB, WARREN, GIRAL, PROBST, STEELE, OTTEN,
D. WILLIAMS, MAYES, KENYATTA, GUENST, MERSKI AND BOYD,
JANUARY 29, 2025
REFERRED TO COMMITTEE ON HEALTH, JANUARY 29, 2025
AN ACT
1 Amending the act of October 24, 2018 (P.L.719, No.112), entitled
2 "An act providing for notification of patient test results to
3 be sent directly to a patient or the patient's designee; and
4 providing for duties of the Department of Health," further
5 providing for definitions, for test results and for duties of
6 Department of Health.
7 The General Assembly of the Commonwealth of Pennsylvania
8 hereby enacts as follows:
9 Section 1. Sections 2, 3 and 4 of the act of October 24,
10 2018 (P.L.719, No.112), known as the Patient Test Result
11 Information Act, are amended to read:
12 Section 2. Definitions.
13 The following words and phrases when used in this act shall
14 have the meanings given to them in this section unless the
15 context clearly indicates otherwise:
16 "Chronic condition." An illness that frequently recurs or
17 persists for a period in excess of three months.
18 "Diagnostic imaging service." A medical imaging test
19 performed on a patient that is intended to diagnose the presence
1 or absence of a disease, including, but not limited to, a
2 malignancy. The term does not include a nonimaging study,
3 including an electrocardiogram, standard electrocardiogram
4 treadmill stress test, cardiac monitor, pulmonary function test
5 or similar test.
6 "Diagnostic radiograph." A projectional radiograph that
7 acquires an image or digital image with x-rays to produce a high
8 contrast, two-dimensional image, otherwise known as an x-ray.
9 "Health care practitioner." As defined in section 103 of the
10 act of July 19, 1979 (P.L.130, No.48), known as the Health Care
11 Facilities Act.
12 ["Significant abnormality." A finding by a diagnostic
13 imaging service of an abnormality or anomaly which would cause a
14 reasonably prudent person to seek additional or follow-up
15 medical care within three months.]
16 Section 3. Test results.
17 [(a) General rule.--When, in the judgment of the entity
18 performing a diagnostic imaging service, a significant
19 abnormality may exist, the entity performing the diagnostic
20 imaging service shall directly notify the patient or the
21 patient's designee by providing notice that the entity has
22 completed a review of the test performed on the patient and has
23 sent results to the health care practitioner who ordered the
24 diagnostic imaging service. The notice shall include all of the
25 following:
26 (1) The name of the ordering health care practitioner.
27 (2) The date the test was performed.
28 (3) The date the results were sent to the ordering
29 health care practitioner.
30 (4) The following statements:
20250HB0409PN0381 - 2 -
1 You are receiving this notice as a result of a
2 determination by your diagnostic imaging service that
3 further discussions of your test results are warranted
4 and would be beneficial to you.
5 The complete results of your test or tests have been or
6 will be sent to the health care practitioner that ordered
7 the test or tests. It is recommended that you contact
8 your health care practitioner to discuss your results as
9 soon as possible.
10 (5) The contact information necessary for the patient to
11 obtain a full report.]
12 (a.1) Written notice at time of service.--The entity
13 performing the diagnostic imaging service shall provide written
14 notice to the patient or the patient's designee at the time of
15 the diagnostic imaging service. The notice shall include the
16 following statement:
17 Your test results will be made available to you once the
18 results are ready. You can access your test results
19 online through your electronic health record (EHR)
20 patient portal. If you do not have access to your online
21 patient portal, you can request that your test results be
22 delivered to you by mail. You may be charged a reasonable
23 fee for the administrative costs of mailing the test
24 results.
25 (b) Exceptions.--The following shall be exempted from the
26 requirements of subsection [(a)] (a.1):
27 (1) Routine obstetrical ultrasounds used to monitor the
28 development of a fetus.
29 (2) Diagnostic imaging services performed on a patient
30 who is being treated on an inpatient basis [or] in an
20250HB0409PN0381 - 3 -
1 emergency [room] department or observation unit of a
2 hospital.
3 (3) Diagnostic radiographs.
4 (4) Diagnostic imaging services performed on a patient
5 with a chronic condition if the patient has previously
6 received notice of the chronic condition.
7 (5) Diagnostic imaging services test results provided to
8 a patient or a patient's designee at the time of the test.
9 [(c) Time.--Except as provided under subsection (d)(2)(v),
10 no later than 20 days after the date the results were sent to
11 the ordering health care practitioner as provided under
12 subsection (a)(3), the entity performing the diagnostic imaging
13 service shall provide the patient or patient's designee with the
14 notice under subsection (a).
15 (d) Method of transmittal.--
16 (1) The notice under subsection (a) shall be provided in
17 a manner deemed acceptable by the patient or the patient's
18 designee.
19 (2) A notice provided under subsection (a) shall be
20 presumed to comply with this act if:
21 (i) mailed in a properly addressed and stamped
22 letter through the United States Postal Service;
23 (ii) sent electronically by e-mail;
24 (iii) sent by automatic alert from an electronic
25 medical record system that the notice under subsection
26 (a) has been posted to the patient's electronic medical
27 record that is presently viewable;
28 (iv) sent by facsimile; or
29 (v) provided directly to the patient at the time of
30 service, so long as the patient acknowledges the receipt
20250HB0409PN0381 - 4 -
1 of the results and signs the patient's medical record
2 accordingly.
3 (e) Construction.--
4 (1) Nothing in this act shall be construed to require an
5 entity to provide a patient or patient's designee the notice
6 under subsection (a) if the results are provided to the
7 patient or patient's designee by the health care practitioner
8 at the time of the test.
9 (2) Nothing in this act shall be construed to prohibit
10 an entity from providing a patient with:
11 (i) the summary of a diagnostic imaging service
12 report, otherwise known as an impression or conclusion;
13 or
14 (ii) the complete results of the diagnostic imaging
15 service provided to the ordering health care
16 practitioner.]
17 (f) Disclosure of test results.--Except as provided under
18 subsection (g), the following test results and any other related
19 results shall not be disclosed to a patient as part of the
20 patient's electronic health record, and in the case of a
21 clinical laboratory test result or pathology report shall not be
22 disclosed by the person or entity that administers and controls
23 the patient's electronic health record, until one full business
24 day has elapsed after the results are finalized, unless the
25 ordering health care practitioner directs the release of the
26 results before the end of that period:
27 (1) Pathology reports or radiology reports that have a
28 reasonable likelihood of showing a finding of malignancy.
29 (2) Tests that could reveal genetic markers.
30 (g) Exception.--The prohibition under subsection (f) shall
20250HB0409PN0381 - 5 -
1 not apply if the test results are provided to a patient or the
2 patient's designee at the time of the test.
3 (h) Policies and procedures.--A health care facility,
4 clinical laboratory or an entity performing a diagnostic imaging
5 service shall develop and implement policies and procedures for
6 providing patient test results in accordance with this section.
7 (i) Face-to-face requirements.--Nothing in this act shall be
8 construed to repeal any law of this Commonwealth that requires a
9 health care practitioner to conduct a face-to-face meeting or
10 counseling session with a patient prior to a test result being
11 disclosed to the patient or being posted in the patient's
12 electronic health record.
13 Section 4. Duties of Department of Health.
14 (a) Reviews and complaints.--The Department of Health
15 shall[:
16 (1) in accordance with law, conduct compliance reviews
17 as part of the inspection performed by the department or an
18 accrediting organization and investigate complaints filed
19 relating to the requirements of section 3; and
20 (2) establish a complaint procedure, which shall be made
21 available on the department's publicly accessible Internet
22 website.] conduct compliance reviews on health care
23 facilities and clinical laboratories licensed or permitted by
24 the department.
25 (b) Limitation.--The Department of Health shall limit the
26 scope of the compliance reviews under subsection (a) to
27 determining whether policies and procedures have been developed
28 and implemented in accordance with section 3(h).
29 Section 2. This act shall take effect in 60 days.
20250HB0409PN0381 - 6 -Connected on the graph
Outbound (3)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| — | referred_to_committee | Pennsylvania Senate Health And Human Services Committee | — | pa-leg | |
| — | referred_to_committee | Pennsylvania House Appropriations Committee | — | pa-leg | |
| — | referred_to_committee | Pennsylvania House Health Committee | — | pa-leg |
The full graph
Every typed relationship touching this entity — 3 edges across 1 category. Grouped by what the connection is; the heaviest few are shown, with a link to the full list.
Committees
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Bridget M. Kosierowski (D, state_lower PA-114) | sponsor | 0 | — | 5 |
| 2 | Arvind Venkat (D, state_lower PA-30) | cosponsor | 0 | — | 1 |
| 3 | Benjamin V. Sanchez (D, state_lower PA-153) | cosponsor | 0 | — | 1 |
| 4 | Bryan Cutler (R, state_lower PA-100) | cosponsor | 0 | — | 1 |
| 5 | Carol Hill-Evans (D, state_lower PA-95) | cosponsor | 0 | — | 1 |
| 6 | Carol Kazeem (D, state_lower PA-159) | cosponsor | 0 | — | 1 |
| 7 | Christopher M. Rabb (D, state_lower PA-200) | cosponsor | 0 | — | 1 |
| 8 | Dan K. Williams (D, state_lower PA-74) | cosponsor | 0 | — | 1 |
| 9 | Danielle Friel Otten (D, state_lower PA-155) | cosponsor | 0 | — | 1 |
| 10 | Ed Neilson (D, state_lower PA-174) | cosponsor | 0 | — | 1 |
| 11 | G. Roni Green (D, state_lower PA-190) | cosponsor | 0 | — | 1 |
| 12 | Gina H. Curry (D, state_lower PA-164) | cosponsor | 0 | — | 1 |
| 13 | Heather Boyd (D, state_lower PA-163) | cosponsor | 0 | — | 1 |
| 14 | III John C. Inglis (D, state_lower PA-38) | cosponsor | 0 | — | 1 |
| 15 | Joe Webster (D, state_lower PA-150) | cosponsor | 0 | — | 1 |
| 16 | Jose Giral (D, state_lower PA-180) | cosponsor | 0 | — | 1 |
| 17 | Keith S. Harris (D, state_lower PA-195) | cosponsor | 0 | — | 1 |
| 18 | Kyle Donahue (D, state_lower PA-113) | cosponsor | 0 | — | 1 |
| 19 | La'Tasha D. Mayes (D, state_lower PA-24) | cosponsor | 0 | — | 1 |
| 20 | Lisa A. Borowski (D, state_lower PA-168) | cosponsor | 0 | — | 1 |
| 21 | Malcolm Kenyatta (D, state_lower PA-181) | cosponsor | 0 | — | 1 |
| 22 | Mandy Steele (D, state_lower PA-33) | cosponsor | 0 | — | 1 |
| 23 | Nancy Guenst (D, state_lower PA-152) | cosponsor | 0 | — | 1 |
| 24 | Perry S. Warren (D, state_lower PA-31) | cosponsor | 0 | — | 1 |
| 25 | Robert E. Merski (D, state_lower PA-2) | cosponsor | 0 | — | 1 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)
By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-20 · was referred to Pennsylvania Senate Health And Human Services Committee · pa-leg
- 2026-05-20 · was referred to Pennsylvania House Appropriations Committee · pa-leg
- 2026-05-20 · was referred to Pennsylvania House Health Committee · pa-leg